Predictions
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Viatris Inc.
Start price
Target price
Perf. (%)
€9.76
18.10.22
18.10.22
-
18.11.26
18.11.26
13.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Viatris Inc.
Start price
Target price
Perf. (%)
€9.76
18.10.22
18.10.22
-
18.11.26
18.11.26
13.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€8.10
27.06.23
27.06.23
€12.00
31.07.26
31.07.26
74.07%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
03.01.23
03.01.23
€10.00
31.12.25
31.12.25
30.22%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.29
06.03.23
06.03.23
-
06.03.24
06.03.24
-13.18%
17.03.23
17.03.23
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.16
27.09.22
27.09.22
-
27.09.23
27.09.23
-4.31%
01.10.22
01.10.22
Risky Investment
AstraZeneca plc
Start price
Target price
Perf. (%)
€91.61
03.06.21
03.06.21
€115.00
03.06.22
03.06.22
34.21%
04.06.22
04.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
AstraZeneca plc
Start price
Target price
Perf. (%)
€91.61
03.06.21
03.06.21
€115.00
03.06.22
03.06.22
34.21%
04.06.22
04.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.42
08.07.21
08.07.21
-
08.07.22
08.07.22
-55.26%
21.05.22
21.05.22